COMP <GO>
ADUS vs AVAH // EV/EBITDA & P/E VALUATION
Addus HomeCare Corporation (NASDAQ) VS. Aveanna Healthcare Holdings Inc. (NASDAQ) • 15-METRIC TALLY: ADUS 6
— AVAH 5
▲ EV/EBITDA & P/E VALUATION LEADER: AVAH
LAST: $124.34 (+1.77%) • MKT CAP: $2.32B
valuation
16.8x
LAST: $13.26 (+1.53%) • MKT CAP: $2.89B
valuation
15.5x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ADUS VS. AVAH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ADUS | AVAH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 32.50% | 33.30% | -0.80 | AVAH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.10% | 15.70% | -6.60 | AVAH | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 16.8x | 15.5x | +1.30 | AVAH | /valuation <GO> |
| Free Cash Flow Yield | 4.47% | 4.35% | +0.12 | ADUS | /fcf-yield <GO> |
| Operating Margin | 9.70% | 10.50% | -0.80 | AVAH | /operating-margins <GO> |
| Net Profit Margin | 6.70% | 0.00% | +6.70 | ADUS | /net-margins <GO> |
| Revenue Growth (YoY) | 23.20% | 20.20% | +3.00 | ADUS | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.83 | 1.86 | +3.97 | ADUS | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 8/9 | +1.00 | ADUS | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 73.1 | 56.0 | +17.07 | ADUS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 20.3x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.32B | $2.89B | -$571.6M | AVAH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ADUS REV | AVAH REV | ADUS GROSS % | AVAH GROSS % | ADUS FCF | AVAH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.42B | $2.43B | 32.5% | 33.3% | $103.8M | $125.9M |
| FY 2024 | $1.15B | $2.02B | 32.5% | 31.4% | $110.4M | $32.6M |
| FY 2023 | $1.06B | $1.90B | — | — | $112.2M | $22.7M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ADUS // BETA —
AVAH // BETA —